Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Faculty who have authored publication Safety and tolerability of ixazomib, an oral proteasome inhibitor, in combination with lenalidomide and dexamethasone in patients with previously untreated multiple myeloma: an open-label phase 1/2 study.

NameTitleDepartmentInstitution
Mehdi H. Hamadani MDProfessorMedicineMedical College of Wisconsin
Parameswaran Hari MDAdjunct ProfessorMedicineMedical College of Wisconsin